New Delhi:ENTOD Pharmaceuticals has dismissed allegations that it made an unethical or false presentation of facts to the media or public about its product, PresVu eye drops.
Nikkhil K Masurkar, CEO, Entod Pharmaceuticals, said in a statement late Thursday evening, "We at ENTOD Pharmaceuticals hereby declare that we have not made any of the unethical or false presentation of facts to the media or public when it comes to PresVu eye drops. All facts disclosed to the media are strictly on the basis of the approved indication for treatment of presbyopia in adults and the Phase 3 clinical trial data generated by us. "
The company further mentioned that the opinions and claims printed in news stories do not represent ENTOD Pharmaceuticals. "Some of the opinions and claims printed in news stories do not represent that of ENTOD Pharmaceuticals or any of its spokespeople. The widespread media interest in such a therapy has been unprecedented and has led to sensationalization of the story."
A top official source from the Drug Controller General of India (DCGI) told ANI that claims made by the company are unethical and false presentation of facts. "This is unethical and false presentation of facts," said the official source. An official explanation has been sought from the company, the source said.